G

GI Innovation Inc
KOSDAQ:358570

Watchlist Manager
GI Innovation Inc
KOSDAQ:358570
Watchlist
Price: 11 820 KRW 3.41%
Market Cap: 522.7B KRW
Have any thoughts about
GI Innovation Inc?
Write Note

Relative Value

The Relative Value of one GI Innovation Inc stock under the Base Case scenario is 13 764.13 KRW. Compared to the current market price of 11 820 KRW, GI Innovation Inc is Undervalued by 14%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
13 764.13 KRW
Undervaluation 14%
Relative Value
Price
G
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
31
vs Industry
15
Median 3Y
117.2
Median 5Y
117.2
Industry
8.1
Forward
2.5
vs History
vs Industry
Median 3Y
-9.3
Median 5Y
-9.3
Industry
23
Forward
2.3
vs History
vs Industry
Median 3Y
-12.6
Median 5Y
-12.6
Industry
23.4
vs History
vs Industry
Median 3Y
-12.2
Median 5Y
-12.2
Industry
27.3
vs History
4
vs Industry
9
Median 3Y
7.2
Median 5Y
7.2
Industry
2.6
vs History
27
vs Industry
12
Median 3Y
109.7
Median 5Y
109.7
Industry
8.1
Forward
2.4
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.6
vs History
vs Industry
Median 3Y
-9.6
Median 5Y
-9.6
Industry
4.3
Forward
3.6
vs History
vs Industry
Median 3Y
-9
Median 5Y
-9
Industry
3.8
Forward
3.7
vs History
vs Industry
Median 3Y
-11.6
Median 5Y
-11.6
Industry
6
vs History
vs Industry
Median 3Y
-11.4
Median 5Y
-11.4
Industry
3.8
vs History
4
vs Industry
17
Median 3Y
13.6
Median 5Y
13.6
Industry
4.8

Multiples Across Competitors

Competitors Multiples
GI Innovation Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
GI Innovation Inc
KOSDAQ:358570
505.1B KRW 109.9 -11.2 -12.2 -11.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 563 478.2 -178 533.6 -216 796.7 -214 322.8
US
Abbvie Inc
NYSE:ABBV
301B USD 5.4 59.2 14.8 22.8
US
Amgen Inc
NASDAQ:AMGN
162B USD 5 38.3 17.8 33.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
127.5B USD 12 -265.7 26.9 28.2
US
Gilead Sciences Inc
NASDAQ:GILD
115.4B USD 4.1 916 10.2 10.2
US
Epizyme Inc
F:EPE
94.1B EUR 1 875.5 -478.6 -521.2 -507.3
AU
CSL Ltd
ASX:CSL
138B AUD 6 33.9 20.9 26
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
88.6B USD 6.4 19 17.5 19.4
US
Seagen Inc
F:SGT
39.3B EUR 18.1 -55.4 -59.5 -53.7
NL
argenx SE
XBRU:ARGX
34.1B EUR 18.5 -129.9 -104.5 -76.1
P/E Multiple
Earnings Growth
KR
G
GI Innovation Inc
KOSDAQ:358570
Average P/E: 213.3
Negative Multiple: -11.2
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -178 533.6 N/A
US
Abbvie Inc
NYSE:ABBV
59.2
412%
US
Amgen Inc
NASDAQ:AMGN
38.3
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -265.7
42%
US
Gilead Sciences Inc
NASDAQ:GILD
916
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -478.6 N/A
AU
CSL Ltd
ASX:CSL
33.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
KR
G
GI Innovation Inc
KOSDAQ:358570
Average EV/EBITDA: 18
Negative Multiple: -12.2
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 796.7 N/A
US
Abbvie Inc
NYSE:ABBV
14.8
28%
US
Amgen Inc
NASDAQ:AMGN
17.8
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.9
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -521.2 N/A
AU
CSL Ltd
ASX:CSL
20.9
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.5
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.5 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
KR
G
GI Innovation Inc
KOSDAQ:358570
Average EV/EBIT: 23.4
Negative Multiple: -11.3
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -214 322.8 N/A
US
Abbvie Inc
NYSE:ABBV
22.8
88%
US
Amgen Inc
NASDAQ:AMGN
33.7
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -507.3 N/A
AU
CSL Ltd
ASX:CSL
26
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.4
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.1 N/A

See Also

Discover More
Back to Top